SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is currently trending due to anticipation surrounding the stock's inclusion in the Russell 1000 index, which many investors expect will trigger significant institutional buying after the upcoming rebalance. The community is also closely monitoring Dr. Patrick Soon-Shiong's recent commentary on global expansion and AI-driven oncology advancements, with widespread discussion focused on whether these catalysts can overcome current short interest and regulatory headwinds.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is gaining momentum as investors anticipate the upcoming 80th event milestone for its Phase 3 REGAL trial, fueling intense speculation about a potential buyout from big pharma. Community sentiment remains highly charged, with intense debate over short interest levels, skyrocketing borrow fees, and the long-term potential of the GPS platform.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is trending as investors speculate on a potential short squeeze, fueled by high short interest and anticipation of a turnaround strategy under new leadership. The community is actively debating the company's valuation, potential buyout scenarios, and recent management changes as they look for signs of a reversal.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is currently experiencing intense downward pressure as institutional selling and macro-driven multiple compression trigger technical breakdowns, leaving investors divided between those viewing the pullback as a generational accumulation opportunity and those anticipating further downside toward triple-digit support levels. Market sentiment remains highly polarized, with the community actively debating the long-term impact of new partnerships against the company's valuation, insider activity, and broader software sector volatility.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras Systems is trending as investors weigh its aggressive growth potential against significant valuation concerns and near-term risks, including upcoming insider share lockup expirations. While the community actively debates whether the company can successfully challenge current AI hardware leaders, sentiment remains split between those betting on long-term technological adoption and others skeptical of current price-to-sales ratios.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending following the announcement of a joint research agreement with Honda, which investors view as critical validation of its solid-state battery technology. The community is actively debating the significance of the news, with many pointing to the partnership as a major de-risking event that suggests growing commercial momentum and potential for additional OEM collaborations.

Backblaze, Inc. operates as a cloud provider for businesses and consumers to store, use, and protect their data. The firm, through its storage cloud platform, provides a foundation for businesses, developers, IT professionals, and individuals to store, backup, and archive data, host content, manage media, and build their applications. It also offers B2 Cloud Storage and Computer Backup services. The company was founded by Timothy Nufire, Gleb Budman, Charles Jones, Kwok Hang Ng and Brian Wilson in 2007 and is headquartered in San Francisco, CA.

Backblaze Inc - Ordinary Shares - Class A

Backblaze is trending as investors react to a transformational five-year, $335 million storage partnership with AI hyperscaler CoreWeave, which significantly enhances the company's revenue visibility and AI infrastructure positioning. While some community members discuss the potential for a share offering to fund growth, others point to strong institutional backing and technical breakouts as signs of a structural re-rating for the small-cap storage provider.

Roundhill ETF Trust - Roundhill Memory ETF

DRAM is surging as investors aggressively position themselves for a memory sector supercycle, with the community closely watching Micron's upcoming earnings as a critical catalyst for the entire HBM and storage ecosystem. While traders are debating the risks of a potential bubble, many are treating recent dips as buying opportunities, viewing the sustained demand from AI hyperscalers as a structural bottleneck that could keep memory pricing elevated for years.

Corning, Inc. engages in the provision of glass for notebook computers, flat panel desktop monitors, display televisions, and other information display applications, carrier network and enterprise network products for the telecommunications industry, ceramic substrates for gasoline and diesel engines in automotive and heavy-duty vehicle markets, laboratory products for the scientific community and polymer products for biotechnology applications, optical materials for the semiconductor industry and the scientific community, and polycrystalline silicon products and other technologies. It operates through the following segments: Optical Communications, Display, Specialty Materials, Automotive, and Life Sciences. The Optical Communications segment is classified into two main product groupings: carrier and enterprise network. The carrier network group consists of products and solutions for optical-based communications infrastructure for services such as video, data, and voice communications. The enterprise network group consists primarily of optical-based communication networks sold to businesses, governments, and individuals for their own use. The Display Technologies segment manufactures glass substrates for flat panel displays, including organic light-emitting diodes and liquid crystal displays that are used primarily in televisions, notebook computers, desktop monitors, tablets, and handheld devices. The Specialty Materials segment is involved in the manufacture of products that provide material formulations for glass, glass ceramics and crystals, and precision metrology instruments and software. The Automotive segment manufactures ceramic substrates and filter products for emissions control in mobile applications around the world as well as technical glass and optic products and solutions for the interior and exterior of vehicles. The Life Sciences segment develops, manufactures, and supplies laboratory products. The company was founded by Amory Houghton Sr. in 1851 and is headquartered in Corning, NY.

Corning, Inc.

Corning is trending as investors capitalize on its role as a foundational "picks and shovels" provider for the AI infrastructure buildout, specifically driven by multi-year partnerships with hyperscalers to supply essential fiber optics and connectivity hardware. The community is actively discussing its potential for long-term growth as a key player in the physical AI layer, with many participants analyzing the stock's recent technical breakout and comparing its strategic importance to other established technology leaders.

FedEx Corp. is a holding company, which engages in the provision of transportation, e-commerce, business services, and business solutions. It operates through the following segments: FedEx Express, FedEx Freight, Corporate, Other, and Eliminations. The FedEx Express segment offers transportation and delivery services. The FedEx Freight segment refers to freight transportation services to business and residences. The FedEx Services segment includes sales, marketing, information technology, communications, customer service, technical support, billing and collection services, and certain back-office functions that support the company's operating segments. The Corporate, Other, and Eliminations segment is involved in the corporate headquarters costs for executive officers and certain legal and finance functions, as well as certain other costs and credits not attributed to the firm's core business. The company was founded by Frederick Wallace Smith on June 18, 1971, and is headquartered in Memphis, TN.

Fedex Corp

FedEx is currently trending following a strong quarterly earnings report that featured a revenue and EPS beat alongside an upgraded full-year outlook. The market is actively discussing the company's resilient performance and its ongoing strategic shift, including the upcoming spin-off of its freight unit, which continues to drive significant investor interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

GALT Stock Surges 22% — On Track For Best Day In Over A Year After FDA Clears Path For Late-Stage Belapectin Trial

Equity

Galectin plans to submit the final trial protocol to the FDA in the third quarter of 2026.


Galectin Therapeutics (GALT) Upgraded to Buy: What Does It Mean for the Stock?

Galectin Therapeutics (GALT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

FY2026 Earnings Estimate for GALT Issued By HC Wainwright

Galectin Therapeutics Inc. (NASDAQ:GALT - Free Report) - Research analysts at HC Wainwright lifted their FY2026 earnings estimates for shares of Galectin Therapeutics in a note issued to investors on...

What is HC Wainwright's Estimate for GALT Q1 Earnings?

Galectin Therapeutics Inc. (NASDAQ:GALT - Free Report) - Equities researchers at HC Wainwright issued their Q1 2026 EPS estimates for shares of Galectin Therapeutics in a note issued to investors on...

Galectin Therapeutics (NASDAQ:GALT) Posts Quarterly Earnings Results, Beats Expectations By $0.02 EPS

Galectin Therapeutics (NASDAQ:GALT - Get Free Report) announced its quarterly earnings results on Tuesday. The company reported ($0.08) EPS for the quarter, beating analysts' consensus estimates of ($0.10) by $0.02...

Galectin Therapeutics Inc. (NASDAQ:GALT) Short Interest Up 27.0% in March

Galectin Therapeutics Inc. (NASDAQ:GALT - Get Free Report) saw a large increase in short interest in the month of March. As of March 13th, there was short interest totaling 6,567,660 shares, an increase of 27.0% from the February 26th total of 5,169,383 shares. Currently, 21.5% of the company's...

Galectin Therapeutics (GALT) Projected to Post Earnings on Monday

Galectin Therapeutics (NASDAQ:GALT) will be releasing its Q4 2025 earnings before the market opens on Monday, March 30. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-3-30-galectin-therapeutics-inc-stock...

Galectin Therapeutics Highlights Belapectin Data in MASH Cirrhosis KOL Event, Eyes Next Steps

Galectin Therapeutics (NASDAQ:GALT) hosted a virtual key opinion leader (KOL) event to discuss belapectin as a potential treatment for patients with metabolic dysfunction-associated steatohepatitis...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Galectin Therapeutics Inc. - GALT

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Galectin Therapeutics Inc. - GALT INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of...

Galectin Therapeutics Inc. (NASDAQ:GALT) Short Interest Update

Galectin Therapeutics Inc. (NASDAQ:GALT - Get Free Report) was the target of a significant drop in short interest during the month of December. As of December 31st, there was short interest totaling...

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

Galectin Therapeutics Inc

Extremely Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$3.12
Prev Close	$2.80
Open	$2.71
Dividend Yield	0.00%
50-Day Moving Average	$2.42
Beta	0.65
Avg. Volume	367,509.97
PE Ratio	-7.61

52-Week High	$7.13
52-Week Low	$2.03
Market Capitalization	$184.4M
EPS (Annual)	-$0.4847
Price to Book	-1.55
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

GALTGalectin Therapeutics Inc

Latest GALT News